MediWound Files for $80 Million Wall Street IPO

Shares of parent company Clal Biotech close 5.2% higher on plan.

comments Print
Joining the parade of Israeli biotech companies marching toward Wall Street, MediWound has filed a draft prospectus with the U.S. Securities and Exchange Commission for an $80 million initial public offering.